AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.8 Out of 5 (6632 Reviews)

KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.

Manish Patil

Manish Patil

Operations Manager

I’m very happy with the NPS service at KSquare. Their personalized advice gave me the clarity I needed.

Namrata Das

Namrata Das

High School Teacher

I never imagined saving for the future could be this easy. KSquare’s SIP service is transparent, reliable, and perfect for professionals like me looking to invest smartly.

Priya Mehta

Priya Mehta

Marketing Manager

With KSquare’s help, I finally understood the benefits of NPS. Their team is responsive and really knows their stuff.

Dinesh Rawal

Dinesh Rawal

Transport Manager

I started my NPS with KSquare last year, and the process was very smooth. I trust them with long-term goals.

Deepika Menon

Deepika Menon

Digital Marketer

Mutual fund investing with KSquare has been fantastic. I appreciate their attention to risk profiling and how they tailor recommendations. It’s an empowering experience.

Kavya Iyer

Kavya Iyer

Biotech Researcher

Thanks to KSquare, I can now invest in India confidently from the US. Their team was extremely helpful and always available when I had questions.

Varun Iyer

Varun Iyer

Finance Manager

The pension solutions offered by KSquare are well-structured. I got real-time assistance and no sales pressure at all.

Saurabh Pratap

Saurabh Pratap

Creative Director

KSquare offered me instant financial flexibility through my portfolio. Their team was responsive and professional.

Siddharth Iyer

Siddharth Iyer

Data Analyst

My dream vacation finally happened through planned SIP savings with KSquare. They track progress regularly and make sure goals never slip. A wonderful financial planning experience for every family.

Sana Khan

Sana Khan

FAQ's

Frequenlty Asked Question

Does KSquare offer customer support for NRIs in different time zones?

Yes, KSquare provides responsive support and scheduling flexibility for NRIs in all global time zones.

Can I set up automatic investments through KSquare?

Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.

Is there a credit score requirement for getting LAMF?

While credit score matters, lenders also consider the value and type of mutual funds pledged. KSquare helps assess your eligibility beforehand.

Is there a lock-in period for mutual fund investments?

Only ELSS funds have a 3-year lock-in. Other funds generally allow you to redeem anytime based on NAV.

Does KSquare assist with KYC for NRI clients?

Yes, KSquare helps NRIs complete the KYC process digitally, making onboarding quick and hassle-free.

How is the loan amount calculated?

The loan value is based on the mutual fund's NAV and the lender’s margin requirements. KSquare shows your eligible amount during application.

What are mutual funds and how do they work?

Mutual funds pool money from many investors to invest in a diversified portfolio of stocks, bonds, or other assets managed by professionals.

Is there any penalty for missing a SIP installment?

No penalties are charged by mutual funds for missing SIPs, but your bank may charge ECS failure fees if funds are insufficient.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.